The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

On August 22, Moderna announced that FDA approved ... On the same day, Pfizer and BioNTech also announced that they received approval for their sBLA for an updated composition of their Omicron ...

When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here's what ...

Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, ...

The FDA approved Moderna's mRESVIA shot for RSV-associated lower respiratory tract disease in adults aged 60 or older last ...

What about the new COVID booster approved ... that RSV vaccines are not recommended annually like the flu vaccine, and one ...

The FDA authorized an updated version of the protein-based Novavax COVID-19 vaccine for use in people 12 and up. Doses could ...

Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...

The Hawaii Department of Health is recommending residents get updated flu and COVID-19 vaccines that are now available.

Moderna has delayed its break-even goal by two years, pushing it to 2028, due to slower regulatory processes for key products like flu and cancer vaccines. The company expects lower sales in 2025 ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, ...